Fresenius reported 14.02 in PE Price to Earnings for its fiscal quarter ending in September of 2026.





Pe Change Date
Akzo Nobel 40.55 16.17 Sep/2026
Alcon AG 42.44 6.03 Jun/2026
AstraZeneca 24.63 0.71 Sep/2026
BASF 9.89 0.14 Sep/2026
Bayer 4.61 0.47 Sep/2026
Beiersdorf 16.75 5.3 Jun/2026
DaVita Healthcare Partners 21.43 7.73 Jun/2026
Demant 20.6 6.87 Jun/2026
E.ON 9.07 19.71 Jun/2026
Essilor 61.39 7.22 Jun/2026
Fresenius 14.02 2.58 Sep/2026
Fresenius Medical Care 8.23 3.9 Sep/2026
Getinge 16.53 4.8 Jun/2026
Givaudan 27.41 4.3 Dec/2025
GlaxoSmithKline 9.72 0.9 Sep/2026
GN Store Nord 9.38 1.39 Jun/2026
GRIFOLS 13.04 1.66 Sep/2026
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Lonza 34.34 2.58 Dec/2025
Merck 17.21 4.47 Jun/2026
Novartis 19.17 3.24 Sep/2026
Philips 23.76 9.44 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
RWE 8.8 1.46 Jun/2026
Sanofi 22.34 3.38 Sep/2026
Smith & Nephew 13.76 3.86 Jun/2026